These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26213314)

  • 1. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence.
    Freeman TP; Winstock AR
    Psychol Med; 2015 Nov; 45(15):3181-9. PubMed ID: 26213314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
    Freeman TP; Morgan CJ; Hindocha C; Schafer G; Das RK; Curran HV
    Addiction; 2014 Oct; 109(10):1686-94. PubMed ID: 24894801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence.
    Hines LA; Freeman TP; Gage SH; Zammit S; Hickman M; Cannon M; Munafo M; MacLeod J; Heron J
    JAMA Psychiatry; 2020 Oct; 77(10):1044-1051. PubMed ID: 32459328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence.
    Petrilli K; Hines L; Adams S; Morgan CJ; Curran HV; Freeman TP
    Addict Behav; 2023 Sep; 144():107740. PubMed ID: 37121087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence.
    Craft S; Winstock A; Ferris J; Mackie C; Lynskey MT; Freeman TP
    Psychol Med; 2020 Oct; 50(14):2364-2373. PubMed ID: 31607281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom.
    Hindocha C; Shaban ND; Freeman TP; Das RK; Gale G; Schafer G; Falconer CJ; Morgan CJ; Curran HV
    Drug Alcohol Depend; 2015 Mar; 148():165-71. PubMed ID: 25622777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands.
    Freeman TP; van der Pol P; Kuijpers W; Wisselink J; Das RK; Rigter S; van Laar M; Griffiths P; Swift W; Niesink R; Lynskey MT
    Psychol Med; 2018 Oct; 48(14):2346-2352. PubMed ID: 29382407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis with high cannabidiol content is associated with fewer psychotic experiences.
    Schubart CD; Sommer IE; van Gastel WA; Goetgebuer RL; Kahn RS; Boks MP
    Schizophr Res; 2011 Aug; 130(1-3):216-21. PubMed ID: 21592732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders.
    Crowley TJ; Macdonald MJ; Whitmore EA; Mikulich SK
    Drug Alcohol Depend; 1998 Mar; 50(1):27-37. PubMed ID: 9589270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.
    Arterberry BJ; Treloar Padovano H; Foster KT; Zucker RA; Hicks BM
    Drug Alcohol Depend; 2019 Feb; 195():186-192. PubMed ID: 30573162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
    Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
    Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of self-reported cannabis dose and potency: an ecological study.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2013 Oct; 108(10):1801-8. PubMed ID: 23627816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour.
    Korf DJ; Benschop A; Wouters M
    Int J Drug Policy; 2007 May; 18(3):168-76. PubMed ID: 17689363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between patterns of cannabis use, abuse and dependence and recent stimulant use: Evidence from two national surveys in Ireland.
    Millar SR; Mongan D; O'Dwyer C; Smyth BP; Perry IJ; Galvin B
    PLoS One; 2021; 16(8):e0255745. PubMed ID: 34370775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults.
    von Sydow K; Lieb R; Pfister H; Höfler M; Wittchen HU
    Drug Alcohol Depend; 2002 Sep; 68(1):49-64. PubMed ID: 12167552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of opportunity to use cannabis and progression from opportunity to dependence: Are influences consistent across transitions?
    Hines LA; Morley KI; Strang J; Agrawal A; Nelson EC; Statham D; Martin NG; Lynskey MT
    Drug Alcohol Depend; 2016 Mar; 160():57-64. PubMed ID: 26811121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
    Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
    Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.